Voraxaze 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification1 
Decision 
Information 
issued on 
Issued2 / 
affected3  
amended 
on 
IB/0022 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
09/02/2024 
SmPC 
life of the finished product - As packaged for sale 
(supported by real time data) 
PSUSA/10968
Periodic Safety Update EU Single assessment - 
08/02/2024 
n/a 
PRAC Recommendation - maintenance 
/202307 
glucarpidase 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
IB/0024 
B.II.b.3.z - Change in the manufacturing process of 
29/01/2024 
n/a 
the finished or intermediate product - Other variation 
IA/0023 
B.I.b.1.c - Change in the specification parameters 
10/11/2023 
n/a 
and/or limits of an AS, starting 
material/intermediate/reagent - Addition of a new 
specification parameter to the specification with its 
corresponding test method 
IA/0021/G 
This was an application for a group of variations. 
05/10/2023 
n/a 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
PSUSA/10968
Periodic Safety Update EU Single assessment - 
31/08/2023 
n/a 
PRAC Recommendation - maintenance 
/202301 
glucarpidase 
IB/0019 
B.II.b.3.a - Change in the manufacturing process of 
31/07/2023 
n/a 
the finished or intermediate product - Minor change 
in the manufacturing process 
IB/0018 
B.II.b.3.z - Change in the manufacturing process of 
07/07/2023 
n/a 
the finished or intermediate product - Other variation 
S/0013 
1st annual re-assessment 
25/05/2023 
n/a 
The CHMP, having reviewed the evidence of compliance 
with the specific obligations and the impact of the data 
Page 2/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IB/0016 
B.I.b.2.c - Change in test procedure for AS or 
25/04/2023 
n/a 
starting material/reagent/intermediate - Other 
changes to a test procedure for a reagent, which 
does not have a significant effect on the overall 
quality of the AS 
IB/0012 
B.I.a.2.a - Changes in the manufacturing process of 
20/03/2023 
n/a 
the AS - Minor change in the manufacturing process 
of the AS 
IA/0015/G 
This was an application for a group of variations. 
23/02/2023 
n/a 
A.7 - Administrative change - Deletion of 
manufacturing sites 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IB/0014 
B.I.a.4.z - Change to in-process tests or limits 
15/02/2023 
n/a 
applied during the manufacture of the AS - Other 
variation 
IB/0011 
B.I.a.4.z - Change to in-process tests or limits 
09/02/2023 
n/a 
applied during the manufacture of the AS - Other 
variation 
submitted by the MAH on the benefit/risk profile of the 
medicinal product, concluded that marketing authorisation 
of Voraxaze should be maintained. 
Page 3/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IB/0010 
B.I.a.2.a - Changes in the manufacturing process of 
09/02/2023 
n/a 
the AS - Minor change in the manufacturing process 
of the AS 
PSUSA/10968
Periodic Safety Update EU Single assessment - 
09/02/2023 
n/a 
PRAC Recommendation - maintenance 
/202207 
glucarpidase 
IB/0008 
B.II.d.z - Change in control of the Finished Product - 
02/02/2023 
n/a 
Other variation 
IA/0009/G 
This was an application for a group of variations. 
18/01/2023 
n/a 
B.II.e.7.b - Change in supplier of packaging 
components or devices (when mentioned in the 
dossier) - Replacement or addition of a supplier 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IA/0007/G 
This was an application for a group of variations. 
16/12/2022 
n/a 
Page 4/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
B.II.e.7.a - Change in supplier of packaging 
components or devices (when mentioned in the 
dossier) - Deletion of a supplier 
II/0004 
B.I.b.1.f - Change in the specification parameters 
22/09/2022 
n/a 
and/or limits of an AS, starting 
material/intermediate/reagent - Change outside the 
approved specifications limits range for the AS 
IB/0003/G 
This was an application for a group of variations. 
27/06/2022 
n/a 
B.II.f.1.e - Stability of FP - Change to an approved 
stability protocol 
B.II.d.1.d - Change in the specification parameters 
and/or limits of the finished product - Deletion of a 
non-significant specification parameter 
B.II.d.1.d - Change in the specification parameters 
Page 5/6 
 
 
 
 
 
 
 
 
 
 
 
 
and/or limits of the finished product - Deletion of a 
non-significant specification parameter 
II/0002 
B.I.b.1.f - Change in the specification parameters 
28/04/2022 
n/a 
and/or limits of an AS, starting 
material/intermediate/reagent - Change outside the 
approved specifications limits range for the AS 
IB/0001 
B.I.a.4.z - Change to in-process tests or limits 
03/03/2022 
n/a 
applied during the manufacture of the AS - Other 
variation 
Page 6/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
